United Therapeutics (UTHR) - Net earnings per share (EPS TTM)

Symbol and logo of brand unither.com (UTHR)

United Therapeutics is implementing energy-efficient systems and solar power generation across its centers. The company is developing carbon-neutral, LEED-certified laboratories for the creation of transplants. This rolling annual earnings per share chart visualizes the income trend, where the value 26.68 serves as the baseline indicator. Leadership in pulmonary hypertension therapy and a monopoly in the orphan segment provide the business with significant pricing power and a stable cash flow.

UTHR (unither.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for United Therapeutics Corp. (UTHR)

- share price and expert price forecast:
General company analysis:unither.com (UTHR)
Mass-produced product of United Therapeutics Corp

This indicator is calculated as the ratio of the company's total net income to the total number of shares outstanding over a rolling year, measuring the actual efficiency of shareholder value generation. By analyzing the 12-month net income per share snapshot, an investor can promptly detect the erosion of United Therapeutics (UTHR) margins resulting from the expansion of pharma behemoths into the narrow pulmonary hypertension therapy niche.

Competitors of United Therapeutics (UTHR)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months BioMarin Pharma (BMRN)|BBIO (BridgeBio) - Net earnings per share (EPS TTM)|BGM: Earnings per share for the trailing year|Net earnings per share for the last 12 months COGT (Cogent Biosciences, Inc.)|XERS (Xeris Biopharma Holdings, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)